Particularly at clinical sites, research teams have had to restructure their team and operations according to institutional directives to prevent the spread of COVID-19 while continuing to offer trial options to patients, with some regions more deeply affected than others.
April 28, 2021
Register for this webinar to explore ways to ensure continuation of critical clinical trial operations through the pandemic and learn strategies for prevention of further delays, how to achieve recovery and resiliency in 2021-2022, and learn more about:
Key risk areas of greatest concern in oncology clinical trials
- Strategies used to mitigate threats in 2020 for small and mid-size US oncology biotechs: what worked and what didn’t
- Cutting-edge small & mid-size oncology biotech trials: where to run them and which aspects may be different moving forward
- What decision factors are expected to most influence your choice of region(s) in 2021-2022, including speed of start-up, participant diversity and regional participation rates
Since early 2020, the oncology clinical trials industry made rapid changes in order to ensure mission critical operations continued to protect participant rights, privacy, safety and data integrity. Particularly at clinical sites, research teams have had to restructure their team and operations according to institutional directives to prevent the spread of COVID-19 while continuing to offer trial options to patients, with some regions more deeply affected than others.
In this live webinar on Tuesday, May 18, 2021 at 1pm EDT (12pm CDT / 10am PDT), Julie Martin, CEO & co-Owner of Scimega Research, will present on key areas of risk to identify and explore within critical clinical trial operations. She will share mitigating tactics & strategies for prevention and recovery, and how to continue to build resiliency in 2021-2022, in order to maximize clinical development progress.
Bonus Offer: Register now and receive immediate free access to the white paper “Expert Guidance to Key Advantages of Canadian Regulatory Landscape”.
For more information, or to register for this event, visit Risk Mitigation for Oncology Clinical Trials.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Share article on social media or email: